// App-Quantinova.ai

e18258 : Three years of reimbursement decisions regarding novel oncology drugs in Israel: A retrospective evaluation of correspondence with the ESMO Magnitude of Clinical Benefit Scale.

Researchers

Presenter

  • Ariel Hammerman

Principal Investigators

  • Sari Greenberg-Dotan

  • Ilan Feldhamer

  • Yair Birnbaum

  • Nathan Cherny

Medical Centers

  • Chief Physician's Office, Clalit Health Services Headquarters, Tel-Aviv, Israel

  • Shaare Zedek Medical Center, Jerusalem, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved